OXIO Health, Inc. – Accelerating Healthcare Solutions
OXIO Health, Inc. – Accelerating Healthcare Solutions OXIO Health is a South Florida-based incubator/accelerator dedicated to reducing today’s steady rise in global healthcare costs worldwide. The OXIO team collaborates with other innovators and entrepreneurs via its Healthcare Ecosystem Platform which invests in the diverse healthcare market. The platform currently has five companies in the portfolio […]
Pluristem Therapeutics Inc. — Focus on Regenerative Medicine
Pluristem Therapeutics Inc. — Focus on Regenerative Medicine Pluristem Therapeutics Inc. (NASDAQ: PSTI) is a clinical-stage biotherapy company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, ischemia, muscle injuries, hematological disorders and exposure to radiation. According to The Sage Group, approximately 65,000-75,000 major amputations (above-the-knee […]
Elevian CEO to Chair and Present at Longevity Therapeutics Summit
Elevian CEO to Chair and Present at Longevity Therapeutics Summit ALLSTON, MA (January 7, 2020) – The 2nd Annual Longevity Therapeutics Summit will be held on January 28-30 in San Francisco, CA. The Summit highlights the latest developments in aging research and therapeutics that target age-related conditions. Elevian CEO, Mark Allen, will chair and present […]
BioXyTran, Inc. – When It Comes to Stroke, Every Second Counts!
BioXyTran, Inc. — Tissue RegBioXyTran, Inc. – When It Comes to Stroke, Every Second Counts! Over 800,000 people this year will succumb to a stroke, so it’s essential to buy critical time to help victims survive and recover. Fortunately, BioXyTran Inc. (OTC: BIXT) has stepped up as a leading late stage biotechnology company dedicated to […]
Travera: Breakthrough Technology for Measuring Cancer Drugs
Client Spotlight Travera: Breakthrough Technology for Measuring Cancer Drugs Travera is using a breakthrough technology to measure which cancer drugs work against each individual’s unique cancer cells. The company is developing a universal biomarker to enable oncologists to quickly determine which drugs to prescribe based on the actual responses of their patients’ tumor cells to […]
Part 1: KINETA, INC – Addressing the Pain Epidemic – Potential Solutions from Seattle based Kineta.
Part 1 KINETA, INC – Addressing the Pain Epidemic – Potential Solutions from Seattle based Kineta. An Interview with Eric Tarcha PhD, Senior Vice President Translational Development In previous articles, our readers were introduced to Kineta, Inc. CEO Shawn Iadonato, and Kristin Bedard. In those articles we shared with our readers the success you have […]
Part 2: KINETA, INC – Addressing the Pain Epidemic – Potential Solutions from Seattle based Kineta.
Part 2 KINETA, INC – Addressing the Pain Epidemic – Potential Solutions from Seattle based Kineta. An Interview with Eric Tarcha PhD, Senior Vice President Translational Development In previous articles, our readers were introduced to Kineta, Inc. CEO Shawn Iadonato, and Kristin Bedard. In those articles we shared with our readers the success you have […]
The Kids Cancer Foundation: Dedicated to our Little Warriors
The Kids Cancer Foundation is a non-profit, 501 (c) (3) charity that provides hope and support to children and families in Palm Beach County battling childhood cancer and/or a blood disorder. The Foundation accomplishes this by providing these children and families with compassionate, easily accessible supportive care services. “Family offices have traditionally been large donors […]
Elevian – Reimagine Aging
Elevian – Reimagine Aging Elevian is a Harvard spin-out developing new medicines that target aging. These drugs have the potential to treat and prevent many age-related diseases at the same time and extend healthy longevity. Groundbreaking research by Elevian’s scientific founders has demonstrated that older animals, when transfused with the blood of young animals, experience […]
How to Invest in Biotech Series – Phases, Stages, and Pitfalls
How to Invest in Biotech Series – Phases, Stages, and Pitfalls By Marc Appel, CEO, Orange Grove Bio Emily Whitehead was 5 years old when she was diagnosed with acute lymphoblastic leukemia, a serious yet the most common type of childhood cancer. Her cancer was resistant to traditional treatments and her prognosis was poor. In […]